Autolus Therapeutics logo

Autolus Therapeutics

AUTL | NASDAQ
Chart Builder DCF Calculator
$1.16
-$0.01 (-0.85%)
At close: Nov 16, 2026, 3:59 PM ET
$1.14
-$0.02 (-1.72%)
After-hours: Nov 16, 2026, 7:39 PM ET
-0.85%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
40
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #528/1021 (Top 52%)

Key Statistics

Market Data

Market Cap $307.42M
1D Range
1.07 1.17
52W Range
1.07 2.54

Valuation (TTM)

PE -1.20
PB 11.22
EV/EBITDA -1.05

Valuation (NTM)

Forward PE N/A
Forward PEG 0.06
Price Target $8.00
Loading financial charts...

Profile

Autolus Therapeutics plc is a clinical-stage biopharmaceutical entity primarily focused on pioneering T-cell-based immunotherapies for various oncological conditions. The company's pipeline includes s...

Sector Healthcare
Industry Biotechnology
Employees 752
IPO Date Jun 22, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.21
Beat 0.00%
REV
$41.24M
Beat +4.30%
Next Earnings
Mar 10, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$8.00
Upside
+589.66%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.